Persbericht

20/09/2018 Oxurion Enrolls First Patient in Phase 2 Clinical Study Evaluating THR-317 (20.9.2018)
19/09/2018 Ageas stelt strategie voor de komende 3 jaar voor (19.9.2018)
19/09/2018 Moury Construct-Communiqué-de-presse-30-juin-2018 (19.9.2018)
19/09/2018 Leasinvest- kapitaalverhoging (19.9.2018)
19/09/2018 Banimmo verkoopt haar residentieel project van 5ha in Vilvoorde (19.9.2018)
19/09/2018 argenx raises approximately $300.6 million in gross proceeds in a U.S. public offering (19.9.2018)
19/09/2018 ASIT biotech presents its 2018 half-year results and provides an update on its clinical programs until end-2019 (19.9.2018
19/09/2018 MONTEA-KENNISNKENNISNAME AANKOOP AANDELEN MONTEA DOOR AANDEELHOUDERS (19.9.2018)
18/09/2018 ENGIE, the leading utility of the Dow Jones Sustainability Index World (18.9.2018)
18/09/2018 Montea zal via sale-and-rent back formule een terrein van 47,9 ha in Tiel (NL) verwerven (18.9.2018)
18/09/2018 Miko-halfjaarresulaten (18.9.2018)
18/09/2018 argenx announces launch of proposed public offering in the United States (18.9.2018)
14/09/2018 ABO-Group - Halfjaarcijfers 2018 (14.9.2018)
17/09/2018 Oxurion to present further scientific findings supporting therapeutic potential of THR-317 & THR-687 as promising new therapies for Diabetic Eye Disease (17.9.2018)
17/09/2018 Orange-Google Chromecast now available for Orange Love customers (17.9.2018)
17/09/2018 ATENOR-AKKOORD OVER DE VERKOOP VAN NAOS IN LUXEMBURG (17.9.2018)
17/09/2018 Leasinvest Real Estate Comm. VA-Leasinvest Real Estate verwerft kantoorgebouw op toplocatie in Europese wijk te Brussel (BE) & sluit belangrijke verhuring af in Cloche d’Or (LU) (14.9.2018)
17/09/2018 WDP realiseert acquisitie van bijkomende site te Zellik via kapitaalverhoging van 5 miljoen euro (17.9.2018)
17/09/2018 argenx reports positive topline results from Phase 2 proof-of-concept trial of efgartigimod in primary immune thrombocytopenia (17.9.2018)
14/09/2018 PCB-Openbaar uitkoopbod aan minderheidsaandeelhouders (14.9.2018)